ReproCELL Incorporated (TYO:4978)

Japan · Delayed Price · Currency is JPY

148.00

-1.00 (-0.67%)

Aug 27, 2026, 12:44 PM JST

ReproCELL Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	2,304	2,233	2,978	2,426	2,953	2,234
Revenue Growth	-18.70%	-25.02%	22.75%	-17.85%	32.18%	73.72%
Gross Profit	1,066	1,015	1,648	1,120	1,141	803
Operating Income	-880	-860	-131	-410	-356	-647
Net Income	-436	-591	103	-31	-305	-575
Earnings Per Share	-4.59	-6.24	1.11	-0.36	-3.62	-7.57
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Research Support Business	1,952	2,415	2,080	2,018	1,381
Medical Business	281.04	564.04	347.16	935.51	853.9
Total	2,234	2,979	2,427	2,953	2,235

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	5,614	6,507	3,941	6,566	6,378	4,641
Total Debt	-	-	-	-	-	80
Net Cash (Debt)	5,614	6,507	3,941	6,566	6,378	4,561
Net Cash Growth	18.97%	65.11%	-39.98%	2.95%	39.84%	0.89%
Net Cash Per Share	59.13	68.71	42.44	76.69	75.72	60.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	-383	6	-11	-140	-246
Capital Expenditures	-	-98	-86	-171	-151	-44
Free Cash Flow	-	-481	-80	-182	-291	-290
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	46.27%	45.45%	55.34%	46.17%	38.64%	35.94%
Operating Margin	-38.19%	-38.51%	-4.40%	-16.90%	-12.06%	-28.96%
Pretax Margin	-18.84%	-26.29%	1.51%	-1.20%	-10.29%	-25.69%
Profit Margin	-18.92%	-26.47%	3.46%	-1.28%	-10.33%	-25.74%
FCF Margin	-	-21.54%	-2.69%	-7.50%	-9.85%	-12.98%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	-	-	135.15	-	-	-
PS Ratio	6.34	7.49	4.68	5.78	6.95	8.31